載入...
Navigating Systemic Therapy in Advanced Thyroid Carcinoma: From Standard of Care to Personalized Therapy and Beyond
Thyroid cancer, with the exception of anaplastic thyroid cancer, typically has very favorable outcomes with the standard therapy. However, those that persist, recur, or metastasize are associated with a worse prognosis. Targeted therapy with kinase inhibitors has shown promise in advanced cases of t...
Na minha lista:
| 發表在: | J Endocr Soc |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Endocrine Society
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6141902/ https://ncbi.nlm.nih.gov/pubmed/30250937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2018-00180 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|